Voluntary industry association representing biosimilar manufacturers, promoting biosimilars as affordable, equivalent alternatives to originator biopharmaceuticals. Delivers education on equivalence and safety and advocates to insurers, physicians, pharmacists and policymakers for fair pricing, competition and improved patient access.